Switch to
Predicate | Object |
---|---|
rdf:type | |
pubmed:issue |
3
|
pubmed:dateCreated |
1976-2-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0025-9284
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
274-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:110-Antiparkinson Agents,
pubmed-meshheading:110-Antipsychotic Agents,
pubmed-meshheading:110-Drug Therapy, Combination,
pubmed-meshheading:110-Humans,
pubmed-meshheading:110-Mental Disorders,
pubmed-meshheading:110-Patient Compliance,
pubmed-meshheading:110-Psychiatric Department, Hospital,
pubmed-meshheading:110-Psychopharmacology
|
pubmed:year |
1975
|
pubmed:articleTitle |
Polypsychopharmacy.
|
pubmed:publicationType |
Journal Article
|